Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;43:131-135
Published online before print November 24, 2003, doi: 10.1161/01.HYP.0000105300.74809.4F
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/1/131    most recent
01.HYP.0000105300.74809.4Fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dina, J. P.
Right arrow Articles by Paiva, T. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dina, J. P.
Right arrow Articles by Paiva, T. B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Restenosis
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies
Right arrow Smooth muscle proliferation and differentiation

(Hypertension. 2004;43:131.)
© 2004 American Heart Association, Inc.


Scientific Contributions

Role of Membrane Potential and Expression of Endothelial Factors in Restenosis After Angioplasty in SHR

Janaina P. Dina; Teresa Feres; Antonio C.M. Paiva; Therezinha B. Paiva

From the Department of Biophysics, Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, Brazil.

Correspondence to Therezinha B. Paiva, MD, PhD, Department of Biophysics, Federal University of São Paulo, Rua Botucatu, 862, 04023-032 São Paulo, SP, Brazil. E-mail tbpaiva{at}biofis.epm.br


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
We examined the roles played by impaired K+ channels, diminished nitric oxide (NO) production, endothelin release, and smooth muscle membrane potential in the increased restenosis observed in spontaneously hypertensive rat (SHR) carotid arteries after angioplasty. The SHR carotid was found to be less polarized than that of normotensive Wistar rats (NWR), and it was further depolarized by the {alpha}2 agonist UK 14,304. This response was blocked by iberiotoxin, indicating that calcium-dependent K+ channels operate normally in the SHR carotid. Acetylcholine caused a hyperpolarization that was significantly smaller in SHR than in NWR carotids, indicating a deficient release of NO in the SHR. After angioplasty, SHR and NWR vessels were depolarized, returning to baseline after 10 days. In the SHR but not in the NWR the contralateral carotid was also depolarized, and this was prevented by the endothelin A/B receptor antagonist bosentan. After angioplasty, endothelin-1 plasma levels increased in both SHR and NWR, but the increase was significantly more prolonged in SHR. We found that the more pronounced restenosis observed in the SHR carotid after angioplasty is not due to impairment of calcium-dependent K+ channels but is related to the relatively depolarized vascular smooth muscles, involving endothelin release caused by reduced NO levels in that strain.


Key Words: rats, spontaneously hypertensive • angioplasty • carotid arteries • muscle smooth, vascular • membranes • endothelin


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
The vascular endothelium plays a role in blood flow control through the release of relaxant and contractile factors. Thus, to prevent overactivation of contractile responses, it releases relaxant factors such as endothelium-derived hyperpolarizing factor, prostanoids, and nitric oxide (NO). The endothelium also prevents the development of vascular lesions by inhibiting platelet aggregation, leukocyte adhesion, and proliferation of vascular smooth muscle cells.1 This protective role is altered in pathological conditions such as arterial hypertension, which is characterized by cell permeability changes, leukocyte adhesion, and smooth muscle cell proliferation. Also, the repair mechanism designed to restore the vessel wall after damage from different causes frequently escapes self-limiting control, resulting in lumen narrowing caused by smooth muscle cell proliferation. These processes are the precursors of atherosclerotic plaque formation, which leads to increased vascular resistance and to restenosis.2

Procedures such as atherectomy performed by balloon injury (angioplasty) widen the lumen but cause extensive endothelium destruction, leaving the vascular wall without protection. This injury stimulates medial smooth muscle cell proliferation and migration to the deendothelized surface to form a neointima. Neointima proliferation and subsequent vascular restenosis are believed to be the main events in the initiation of the atherosclerosis that limits the long-term efficacy of percutaneous transluminal coronary angioplasty.3

It is well accepted that reduction in nitric oxide activity accounts for endothelial dysfunction, since NO donors reduce intimal hyperplasia4,5 and oxidative stress aggravates this process.6 Moreover, there is evidence that endothelin is an important factor in neointima formation after vascular injury.7 Elevated endothelin plasma levels were found in patients after angioplasty.8

In spontaneously hypertensive rat (SHR) carotid arteries, Clowes and Clowes9 attributed increased neointima formation after balloon injury to the hypertensive state. Jandeleit-Dahm et al10 reported similar results in renovascular hypertensive rats but proposed that the restenosis could be due to the increased concentration of angiotensin-converting enzyme found in these animals. Furthermore, effective antihypertensive dosages of verapamil did not prevent neointima formation in SHR,11 indicating that the hypertensive state is not responsible for the restenosis after arterial injury in SHR. Other genetic factors besides the hypertensive state are probably responsible for the increased restenosis in this strain. In addition, SHR presented a more pronounced proliferative response to balloon injury than renovascular hypertensive or normotensive rats.12 Since resting membrane potential measurements showed that the SHR carotid smooth muscle cells are depolarized in comparison to those of either renovascular hypertensive or normotensive rats, the authors concluded that the depolarized state rather than the hypertension could account for the increased proliferative response in SHR.

In previous articles,13,14 we reported that SHR mesenteric artery smooth muscles are less polarized than those of normotensive Wistar rats (NWR). This was attributed to different alterations, such as impairment of the activity of K+ channels coupled to {alpha}2-adrenoceptors or diminished NO production in the SHR.

In the present work, we investigated the role of K+ channels and NO production in the smooth muscle cell membrane potentials of carotid arteries of SHR and NWR. We also followed the effect of angioplasty on the smooth muscle cell membrane potentials of injured and contralateral vessels and on the endothelin plasma levels in these animals.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
Chemicals
Acetylcholine chloride and iberiotoxin were purchased from Sigma Chemical Co, Bosentan was from Actelion, and UK 14,304 (5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine) was from Research Biochemicals International. The other chemicals were products of the highest analytical grade from Merck Darmstadt.

Animals
Experiments were carried out with the use of male Okamoto-Aoki15 SHR and NWR rats, 20 to 30 weeks old, weighing 250 to 300 g.

Injury Model
The animals were anesthetized by intraperitoneal injection of 20 mg/kg body wt thionembutal (Abbott) and 30 mg/kg body wt chloral hydrate, and the left external and common carotid arteries were exposed. With the aid of a micrometer and magnifying glass, the external diameter of the common carotid artery was measured in situ and used for calibrating balloon expansion. A balloon catheter was passed through the external carotid artery and advanced into the aorta, inflated with saline, and pulled back to distend the common carotid artery to 1.2 times its external diameter. The latter procedure was repeated twice, after which the external carotid artery was ligated and the incision was sutured. The extent of neointima formation obtained by this procedure, checked by histomorphometric analysis,12 was found to be {approx}20% greater in the SHR than in the NWR.

Membrane Potential Measurements
Carotid artery rings were placed in a 2-mL perfusion chamber, superfused at a rate of 3 mL/min with Krebs-Henseleit solution maintained at 37°C, and bubbled with a 5% CO2–95% O2 mixture. After an equilibration period of 40 minutes under an optimal resting tension of 1.0 g, membrane potentials were recorded by means of microelectrodes constructed by pulling capillaries in a horizontal puller (Narishige, model PN3). The pipettes were filled with 2 mol/L KCl and had tip resistance of 20±40 mol/L{Omega}. The electrodes were mounted in Ag/AgCl half-cells on a micromanipulator (Leitz) and connected to an electrometer (WP Instruments, model FD 223). The signals were recorded in a potentiometric chart recorder (ECB, model RB102). Rings of 1-cm length were cut from the carotid artery, placed in a 2-mL perfusion chamber, and superfused at a rate of 3 mL/min with Krebs solution of the following composition (in mmol/L): NaCl 137; NaHCO3 5.9; KHCO3 5.9; CaCl2 2.3; MgCl2 1.2; glucose 11.8. The solution was bubbled with 5% CO95% O2 gas mixture and maintained at 37°C, pH 7.4. The impalements were made directly in the smooth muscle cells from the adventitial side. The successful implantation of the electrode was evidenced by a sharp drop in voltage on entry into a cell, a stable potential (±3 mV) for at least 1 minute after impalement, and a sharp return to zero on exit. The time of contact of the drugs with the preparations before the impalements was 10 minutes.

Plasma Endothelin-1 Measurements
Blood samples, collected in glass tubes containing 50 µL Liquemine (Roche), were centrifuged at 2000g for 10 minutes at 4°C, and 2 mL plasma was acidified with 0.25 mL 2 mol/L HCl and centrifuged at 10 000g for 5 minutes, then loaded onto a 500 mg Amprep C2 column (Amersham) previously equilibrated with methanol followed by water. The column was washed with 5 mL water, 0.1% trifluoroacetic acid, and 80% HPLC grade methanol in water. The eluate was dried under nitrogen, the pellet was reconstituted in 250 µL assay buffer, and 100-µL duplicates were taken for quantitative enzyme-linked immunosorbent assay (ELISA) with the use of a Biotrack kit (Amersham) according to the manufacturer’s instructions.

Statistics
Statistical analysis was carried out by 1-way ANOVA followed by the Newman-Keuls test in the case of pairwise comparisons between groups. Data are expressed as mean±SEM. When the data consisted of repeated observations at successive time points, ANOVA for repeated measurements was applied to determine differences between groups. When more than one impalement was made on the same ring from the same rat, the measurements were averaged and considered as n=1. Differences were considered significant at a value of P<0.05.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
Effects of UK 14,304 and Iberiotoxin on Membrane Potentials
SHR carotid smooth muscle membrane potentials were significantly less negative (depolarized) than those of NWR (Figure 1). To determine the role of calcium-dependent K+ channels in this relatively depolarized state of the SHR, we examined the effect of UK14,304, an opener of these channels, on the membrane potential of both hypertensive and normotensive animals.



View larger version (48K):
[in this window]
[in a new window]
 
Figure 1. Membrane potentials measured in carotid artery rings from NWR and SHR in the absence (RMP) and presence of 1 nmol/L UK14,304 alone or together with 10 nmol/L iberiotoxin (IBTX). For each ring obtained from individual rats (number shown in parentheses below bars), 5 to 12 cells were impaled, and averages of respective measurements were used to obtain mean±SEM. *P<0.05 vs respective RMP (Newman-Keuls test).

Figure 1 shows that the SHR carotid membrane potential was increased by UK 14,304, and this response was totally blocked by the addition of iberiotoxin, an inhibitor of calcium-dependent K+ channels. This indicates that these channels operate normally in the SHR carotid.

The role of EDRF was tested in SHR and NWR carotid rings by means of the responses to acetylcholine. As shown in Figure 2, the hyperpolarization induced by this agonist was significantly smaller in SHR (-12.2 mV) than in NWR (-18.6mV), indicating a deficient release of NO in the SHR carotids.



View larger version (43K):
[in this window]
[in a new window]
 
Figure 2. Membrane potentials measured in carotid artery rings from NWR and SHR in the absence (RMP) and presence of 10 µmol/L acetylcholine (ACh). For each ring obtained from individual rats (number shown in parentheses below bars), 4 to 7 cells were impaled, and averages of respective measurements were used to obtain mean±SEM. *P<0.05 vs respective RMP (Newman-Keuls test).

Evolution of Membrane Potentials of Injured and Contralateral Carotids After Angioplasty
Figure 3 shows the membrane potentials measured at different times after angioplasty in the injured and in the contralateral carotid arteries in NWR and SHR. In both strains, a significant depolarization was present in the injured vessels 2 days after surgery, and the membrane potentials remained at the same depolarized level until the 7th day, returning to normal values by the 10th day. In the contralateral vessels, however, a different behavior was observed in the two strains. In the SHR, the contralateral vessels showed a depolarization and time course of recovery similar to those of the injured vessels (Figure 3B). This parallelism between the ipsilateral and contralateral carotid membrane potentials after angioplasty was not observed in the NWR (Figure 3A).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 3. Resting membrane potential measurements in injured (•) and contralateral ({circ}) carotid artery rings from NWR (A) and SHR (B) at different times after angioplasty. Values are averages and standard errors from 5 to 7 animals; for each ring, average of 6 to 12 impalements were used. *P<0.05 vs respective initial value (Newman-Keuls test).

The responses of ipsilateral and contralateral arteries to UK 14,304, as well as their inhibition by IBTX, measured 5 days after angioplasty, were not significantly different from those measured before the procedure was performed (not shown).

Plasma Endothelin Concentration Before and After Angioplasty
The finding that injured and contralateral carotids from SHR undergo similar depolarization after surgery suggests the participation of a humoral factor released from the injured carotid into the circulation. In view of reports of endothelin release after mechanical lesion of endothelial cells,16 measurements of this peptide’s plasma levels before and after angioplasty were performed.

Endothelin-1 plasma levels in the SHR and the NWR were not significantly different, and a marked increase in the plasma concentration of this peptide was observed in both strains by the fourth day after surgery (Figure 4). By the 7th day, the endothelin level had returned to normal in the NWR but remained high in the SHR, returning to normal by the 15th day.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 4. Plasma endothelin-1 concentrations in NWR ({circ}) and SHR (•) at different times after angioplasty. Values are average standard deviations of 3 to 5 determinations.

To determine whether endothelin release was responsible for the parallelism between the depolarizations of injured and contralateral carotids in the SHR, membrane potentials were measured in these arteries before and 2 days after angioplasty, in the presence and in the absence of the endothelin A/B receptor antagonist bosentan. Figure 5 shows that this endothelin antagonist prevented the depolarization of both carotids, indicating that endothelin release may be responsible for the depolarization observed in the contralateral vessel.



View larger version (48K):
[in this window]
[in a new window]
 
Figure 5. Membrane potentials measured in carotid artery rings from SHR in the absence (RMP) and presence of 3 µmol/L bosentan. For each ring obtained from individual rats (number shown in parentheses below bars), 5 to 7 cells were impaled, and averages of respective measurements were used to obtain mean±SEM. *P<0.05 vs respective RMP (Newman-Keuls test).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowConclusions
down arrowReferences
 
Neointima formation after arterial lesion is the initial phase in the development of the atherosclerotic lesion after angioplasty and NO4–6 or endothelin7,16,17 were reported to be involved in this process. Since in SHR these two aggravating factors for neointima proliferation are present, this strain is an interesting model that could simulate the conditions found in human essential hypertension, although it must be acknowledged that balloon injury of nonatheromatous SHR arteries is more severe than the typical angioplasty used clinically.

To determine whether impaired K+ channel activity could be responsible for the relative depolarized state of the SHR carotid smooth muscle cells, we stimulated these channels with the {alpha}2-agonist UK 14,304. This caused a marked hyperpolarization that was completely abolished by iberiotoxin, an inhibitor of these channels, indicating that they are functioning normally in the SHR.

Our finding that the altered membrane potential observed in SHR carotids is not due to impaired K+ channels agrees with previous reports based on patch-clamp measurements of K+ currents in SHR18 and in aldosterone-induced hypertensive rats19. However, these findings contrast with a report of decreased KCa currents in angiotensin-induced hypertension20. This disagreement may be due to the differences between genetic and acquired models of hypertension.

We have also studied the NO release in SHR and NWR carotid arteries by means of the membrane potential response to acetylcholine. The hyperpolarization induced by this agonist was lower in the SHR than in the NWR vessels, indicating that NO release was deficient in the hypertensive animals. This agrees with previous findings in SHR mesenteric arteries14 and in cultured endothelial cells, which show NO deficiency in SHR21 caused by increased destruction by super oxide.22,23 We followed the changes of carotid smooth muscle membrane potential as well as endothelin plasma concentration for several days after angioplasty (Figures 3 and 4 Up). Before this procedure, no difference was found between the endotelin-1 plasma levels of SHR or NWR, in agreement with previous reports.24,25 Thus, endothelin release does not appear to be responsible for the depolarized state of the intact carotid in the SHR relative to the NWR, although higher local endothelin concentrations in the vascular wall might explain the depolarization. After angioplasty, a depolarization of the injured vessel was observed in both the SHR and the NWR, which, however, lasted longer in the SHR. The endothelin plasma levels were also increased in the two strains but were also more persistent in the SHR. This could be due to the reduced NO concentration in this strain, since NO is known to impair endothelin production.25,26 The more pronounced endothelin release into the circulation after angioplasty in the SHR was probably responsible for the parallel depolarizations of injured and contralateral arteries in this strain. Although the contralateral vessels were depolarized to the same extent as the injured carotids, they did not develop restenosis, since the endothelium was intact.


*    Conclusions
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*Conclusions
down arrowReferences
 
In conclusion, we have found that the more pronounced restenosis observed in the SHR carotid after angioplasty is not due to impairment of calcium-dependent K+ channels but is related to the relatively depolarized vascular smooth muscles, involving endothelin release caused by reduced NO levels in that strain.

Perspectives
Our results demonstrate that the increased restenosis observed in SHR after angioplasty is favored by vascular smooth muscle cell depolarization caused by increased plasma endothelin concentration as the result of lower NO production. KCA channels are not impaired in this animal model of hypertension. Neointima formation after angioplasty may be reduced by procedures that decrease vascular smooth muscle depolarization such as endothelin blockade by specific inhibitors or by increasing the plasma NO concentration.


*    Acknowledgments
 
This work was supported by grants and fellowships from the São Paulo State Research Foundation (FAPESP) and by the Brazilian National Research Council (CNPq). We are grateful to Nelson Farias for some of the experimental data and to Nelson Alves Mora for competent technical assistance.

Received August 26, 2003; first decision October 3, 2003; accepted October 24, 2003.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
up arrowConclusions
*References
 
1. Egashira K. Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease. Circ J. 2002; 66: 529–533.[CrossRef][Medline] [Order article via Infotrieve]

2. Schwartz SM, deBlois D, O’Brien ER. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995; 77: 445–465.[Free Full Text]

3. Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1985; 6: 369–375.[Abstract]

4. Taguchi J, Abe J, Okazaki H, Takuwa Y, Kurokawa K. L-Arginine inhibits neointimal formation following balloon injury. Life Sci. 1993; 53: 387–392.[CrossRef]

5. Lee JS, Adrie C, Jacob HJ, Roberts JD Jr, Zapol WM, Bloch KD. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ Res. 1996; 78: 337–342.[Abstract/Free Full Text]

6. Azevedo LC, Pedro MA, Souza LC, de Souza HP, Janiszewski M, da Luz PL, Laurindo FR. Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc Res. 2000; 47: 436–445.[Abstract/Free Full Text]

7. Viswanathan M, Oliveira AM, Jöhren O, Saavedra JM. Increased endothelin ETA receptor expression in rat carotid arteries after balloon injury. Peptides. 1996; 18: 247–255.

8. Ino T, Ohkuro M, Shimazaki S, Akimoto K, Nishimoto K, Iwahara M, Yabuta K, Hosoda Y. Plasma endothelin concentration: relation with vascular resistance and comparison before and after balloon dilatation procedures. Eur J Pediatr. 1992; 51: 416–419.[CrossRef]

9. Clowes AW, Clowes MM. Influence of chronic hypertension on injured and uninjured arteries in spontaneously hypertensive rats. Lab Invest. 1980; 43: 535–541.[Medline] [Order article via Infotrieve]

10. Jandeleit-Dahm K, Burrell LM, Johnston CI, Koch KM. Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive rats. J Hypertens. 1997; 15: 643–650.[CrossRef][Medline] [Order article via Infotrieve]

11. Clozel JP, Powell JS, Kuhn H, Muller RK, Hefti F, Baumgartner HR. Vascular protection with cilazapril. Drugs. 1991; 41 (suppl 1): 62–67.[Medline] [Order article via Infotrieve]

12. Dalle Lucca SLD, Dalle Lucca JJ, Borges ACR, Ihara SSM, Paiva TB. Abnormal proliferative response of the carotid artery of spontaneously hypertensive rats after angioplasty may be related to the depolarized state of its smooth muscle cells. Braz J Med Biol Res. 2000; 33: 919–927.[Medline] [Order article via Infotrieve]

13. Feres T, Borges ACR, Silva EG, Paiva ACM, Paiva TB. Impaired function of alpha-2 adrenoceptors in smooth muscle of mesenteric arteries from spontaneously hypertensive rats. Br J Pharmacol. 1998; 125: 1144–1149.[CrossRef][Medline] [Order article via Infotrieve]

14. Borges ACR, Feres T, Vianna LM, Paiva TB. Recovery of impaired K+ channels in mesenteric arteries from spontaneously hypertensive rats by prolonged treatment with cholecalciferol. Br J Pharmacol. 1999; 127: 772–778.[CrossRef][Medline] [Order article via Infotrieve]

15. Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J. 1963; 27: 282–292.[Medline] [Order article via Infotrieve]

16. Douglas SA, Ohlstein EH. Endothelin-1 promotes neointima formation after balloon angioplasty in the rat. J Cardiovasc Pharmacol. 1993; 22: S371–S373.[CrossRef][Medline] [Order article via Infotrieve]

17. Douglas SA, Louden C, Vickery-Clark LM, Storer BL, Hart T, Feuerstein GZ, Elliott JD, Ohlstein EH. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty: protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res. 1994; 75: 190–197.[Abstract/Free Full Text]

18. England SK, Wooldridge TA, Stekiel WJ, Rusch NJ. Enhanced single-channel K+ current in arterial membranes from genetically hypertensive rats. Am J Physiol. 1993; 264: 1337–1345.

19. Liu Y, Jones AW, Sturek M. Ca(2+)-dependent K+ current in arterial smooth muscle cells from aldosterone-salt hypertensive rats. Am J Physiol. 1995; 269: H1246–H1257.[Medline] [Order article via Infotrieve]

20. Amberg GC, Bonev AD, Rossow CF, Nelson MT, Santana LF. Modulation of the molecular composition of large conductance, Ca(2+) activated K(+) channels in vascular smooth muscle during hypertension. J Clin Invest. 2003; 112: 717–724.[CrossRef][Medline] [Order article via Infotrieve]

21. Brovkovych V, Stolarczyk E, Oman J, Tomboulian P, Malinski T. Direct electrochemical measurement of nitric oxide in vascular endothelium. J Pharm Biomed Anal. 1999; 19: 135–143.[CrossRef][Medline] [Order article via Infotrieve]

22. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, Malinski T. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension. 1995; 26: 854–857.[Abstract/Free Full Text]

23. Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA. Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension. 1999; 33: 1353–1358.[Abstract/Free Full Text]

24. Li J-S, Schiffrin EL. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension. 1995; 25: 495–500.[Abstract/Free Full Text]

25. Lavallée M, Takamura M, Parent R, Thorin E. Crosstalk between endothelin and nitric oxide in the control of vascular tone. Heart Fail Rev. 2001; 6: 265–276.[CrossRef][Medline] [Order article via Infotrieve]

26. Alonso D, Radomski MW. The nitric oxide-endothelin-1 connection. Heart Fail Rev. 2003; 8: 107–115.[CrossRef][Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. G. Denniss and J. W. E. Rush
Impaired hemodynamics and endothelial vasomotor function via endoperoxide-mediated vasoconstriction in the carotid artery of spontaneously hypertensive rats
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1038 - H1047.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. J. Gomes and E. Buffolo
Coronary stenting and inflammation: implications for further surgical and medical treatment.
Ann. Thorac. Surg., May 1, 2006; 81(5): 1918 - 1925.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/1/131    most recent
01.HYP.0000105300.74809.4Fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dina, J. P.
Right arrow Articles by Paiva, T. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dina, J. P.
Right arrow Articles by Paiva, T. B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Restenosis
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies
Right arrow Smooth muscle proliferation and differentiation